AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,428 | 455 | 1,173 | 1,583 | 1,101 |
| Gross Profit | 1,428 | 455 | 1,173 | 1,583 | 1,101 |
| Operating Expenses | 20,299 | 18,873 | 21,373 | 25,085 | 22,649 |
| Operating Income | -18,871 | -18,418 | -20,199 | -23,502 | -21,547 |
| Interest Expense | 83 | 52 | 58 | 61 | 60 |
| Other Income | 66 | 109 | 442 | -2,123 | 439 |
| Pre-tax Income | -18,888 | -18,362 | -19,815 | -25,685 | -21,168 |
| Net Income Continuous | -18,888 | -18,362 | -19,815 | -25,685 | -21,168 |
| Net Income | $-18,888 | $-18,362 | $-19,815 | $-25,685 | $-21,168 |
| EPS Basic Total Ops | -0.19 | -0.18 | -0.20 | -0.25 | -0.21 |
| EPS Basic Continuous Ops | -0.19 | -0.18 | -0.20 | -0.26 | -0.21 |
| EPS Diluted Total Ops | -0.19 | -0.18 | -0.20 | -0.25 | -0.21 |
| EPS Diluted Continuous Ops | -0.19 | -0.18 | -0.20 | -0.26 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.18 | -0.20 | -0.25 | -0.21 |
| EBITDA(a) | $N/A | $-17,706 | $-19,387 | $-22,686 | $-20,866 |